Vizlitics Inc. – Trademark Portfolio
Entity Type: 03
Vizlitics Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VIZLITICS. The owner is based in Chappaqua, NY.
32 Random Farms Cir.
Chappaqua, NY 10514
Showing of trademarks Trademarks
Trademark Classifications
Vizlitics Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Vizlitics Inc. have?
Vizlitics Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Vizlitics Inc. file in?
Vizlitics Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Vizlitics Inc.'s most well-known trademarks?
Vizlitics Inc.'s registered trademark portfolio includes well-known marks such as VIZLITICS. These are among 1 currently registered trademark in the portfolio.
What is Vizlitics Inc.'s trademark registration success rate?
Vizlitics Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.